Project description
Paving the way to universal replacement of in vitro and in vivo with in silico
Computer models informed by experimental data enable us to test hypotheses and make predictions, significantly streamlining the research and development cycle relative to trial and error. When it comes to medicine, experimentation relies on biological samples ranging from cultured cells to whole animals, so increased reliance on modelling has additional benefits. Harnessing Big Data and tremendous advances in computing power could pave the way to minimising and eventually eliminating the need for anything other than in silico 'experimentation' in medical research and development. The EU-funded ISW project will bring together a large European consortium and a multi-stakeholder advisory board to lay the groundwork to achieve this goal with attention to the models, regulation, standardisation and more.
Fields of science
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugs
- medical and health sciencesbasic medicineneurologymultiple sclerosis
- medical and health sciencesclinical medicinepneumologytuberculosis
- medical and health sciencesclinical medicineorthopaedics
- medical and health sciencesclinical medicineendocrinology
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
40126 Bologna
Italy
See on map
Participants (14)
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
40136 Bologna
See on map
1012WX Amsterdam
See on map
5612 AE Eindhoven
See on map
95131 Catania
See on map
3001 Heverlee
See on map
30-072 Krakow
See on map
3000 Leuven
See on map
34123 Trieste
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
4000 Liege
See on map
3015 GD Rotterdam
See on map
1111 Budapest
See on map
10787 Berlin
See on map
95125 Catania
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
3583 Beringen
See on map